Individual decision · SEC · 30 Mar 2009

SEC Division of Corporation Finance no-action letter: Icahn Associates Corp.

Icahn requests confirmation that the SEC Staff will not recommend enforcement action for violations of Section 14(a) of the Securities Exchange Act of 1934 and Rule 14a-4 of Regulation 14A. The request concerns a proxy solicitation by Icahn Partners LP and affiliated funds, who hold approximately 9.43% of Amylin Pharmaceuticals, Inc. common stock. Icahn proposes a proxy card allowing votes for its own minority slate, all other Icahn nominees, and all other nominees from a second minority slate by Eastbourne Capital Management L.L.C., which holds approximately 12.5% of the stock. The Staff's non-action would permit this voting structure despite the absence of explicit rule provisions for two competing non-management minority slates.

US FederalSecurities and Exchange Commission

Lineage

The documents this one cites, and the documents that cite it.

Securities Exchange Act of 19341934 · US-LAWSecurities Exchange Act of 1934 (1934-06-06)SEC Division of CorporationFinance no-action letter: Ica…2009-03-30 · this documentSEC Division of Corporation Finance no-action letter: Icahn Associates Corp. (2009-03-30)
amendssupersedesissued underrefers todashed card: not in RegAlert (or proposed)arrows run from the older text to the one that changes it
The links and the sentences they come from (1)
Issued under
  • “violations under Section 14(a) of the Securities Exchange Act of 1934 (the "1934 Act"), 15 U.S.C. § 78n”

More like this from SEC

SEC published 7 documents in the last 30 days. We email you each new one the day it's published.

Source: Securities and Exchange Commission — original document · Summary generated with machine assistance and reviewed before publication; the authoritative text is the regulator's original document. How RegAlert works

In RegAlert: added · updated